Universidad Nacional de Colombia   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bogota Colombia (1867)

Organization Overview

First Clinical Trial
2006
NCT00609375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Clinica Palermo, Bogota | Full Professor School of Medicine. Microbiology Department. | Fundación San Carlos, Bogota | Hospital Universitario Nacional de Colombia | Instituto Nacional de Cancerología | Universidad Nacional de Colombia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacteremia (Phase 4)

Blepharitis (Phase 3)

Breast Neoplasms (Phase 2)

Coronavirus Infections (Phase 3)

Dry Eye Syndromes (Phase 3)

Keratoconjunctivitis Sicca (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Sjogren's Syndrome (Phase 3)

Triple Negative Breast Neoplasms (Phase 1)

Uterine Cervical Neoplasms (Phase 2)

Vaginal Discharge (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 26